Medco Investors Fight $29B Sale To Express Scripts
A Medco Health Solutions Inc. shareholder launched a class action Monday in Delaware designed to derail Express Scripts Inc.'s $29.1 billion purchase of the rival pharmacy benefit manager, echoing a claim...To view the full article, register now.
Already a subscriber? Click here to view full article